About this episode
We showcase the long-anticipated Australian launch of Profhilo, a bio-remodelling filler made by IBSA. George Kypreos is Managing Director of Dermocosmetica, and we welcome back Dr Cara McDonald (Episodes 89 and 166), one of Australia's new Profhilo KOLs.
We discuss George's background, the lengthy approval process for a new filler in Australia, who IBSA are, a recap on skin ageing, what bio-remodelling means and how it differs from skin boosters, how Profhilo's production and crosslinking differ from other hyaluronic acid fillers and why that matters for rheology, and what comes in the box.
We also cover ideal patients, the BAP technique, the best areas of the face and body, managing expectations, where it fits in your portfolio, downtime, complications from six-plus years of European experience, training, purchasing and the launch events.
What you'll learn
- What bio-remodelling means
- How Profhilo differs from other hyaluronic acid fillers
- Ideal patients and the BAP technique
- Managing expectations and downtime
- Safety data from the European experience
Topics
- Profhilo
- Bioremodelling
- Hyaluronic acid
- IBSA
- Skin quality
- Australia
Full transcript
The full transcript for this episode is coming soon.